161. 家族性良性慢性天疱瘡 Disease details / Clinical trials / Drug dev / DR info /

臨床試験数 : 5 / 薬物数 : 9 - (DrugBank : 4) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 24

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

(E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime
   Dermecular Therapeutics, Inc.
      2018   Phase 1;Phase 2   EUCTR2018-000373-80-FR   France;
Botulism Toxin Treatment
   University Hospital, Toulouse
      2015   Phase 1   NCT02782702   -
Celecoxib
   Juntendo university gradurate school of medicine
      2013   -   JPRN-UMIN000010191   Japan;
Doxycycline
   Gangnam Severance Hospital
      2020   -   NCT05007223   Korea, Republic of;
LX3305 250 mg capsule
   Dermecular Therapeutics, Inc.
      2018   Phase 1;Phase 2   EUCTR2018-000373-80-FR   France;
None
   Dermecular Therapeutics, Inc.
      2018   Phase 1;Phase 2   EUCTR2018-000373-80-FR   France;